The Chinese biotech is also entitled to an equity stake in Oblenio Bio, according to the release. Leads developed LBL-051 ...

More U.S. investors are launching companies stateside that license technology from China, even as Congress moves to crack down on some Chinese companies through the BIOSECURE Act. Read more.

Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of ...

GSK Plc acquired an experimental drug from Chinese biotech firm Chimagen Biosciences for as much as $850 million, adding to ...

U.S. drugmakers and biotechs have come to rely on Chinese partners for manufacturing, research and ingredients. Now, some of ...

The five-year investment will go toward the construction of a new R&D facility in Beijing to develop innovative therapies and integrate the world’s second most populated country into the company’s ...

Discover the major biotech partnerships, collaborations, and mergers and acquisitions that made headlines in October 2024.

There is no mechanism for Chinese companies to refuse a Communist Party request for data. In addition, BGI is regarded as a champion in Beijing’s efforts to lead the world in biotechnology and ...

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...

As the US presidential election nears, investors in Chinese stocks are zeroing in on the prospects of key sectors that look ...

The Federal Government has signed a Memorandum of Understanding (MoU) with WONDFO BIOTECH Ltd., a global leader in the ...

U.S. drugmakers and biotechs have come to rely on Chinese partners for manufacturing, research and ingredients. Now, some of them are looking for alternatives as geopolitical tensions rise.